Advanced Enzyme Technologies Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Ltd. regarding the availability of audio recording from their earnings conference call.
The disclosure is made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended). This intimation follows a previous communication dated October 26, 2026 that announced the conference call for analysts and investors.
The conference call was held on Tuesday, November 03, 2026 to discuss the company's unaudited financial results for the quarter and half year ended September 30, 2026. The audio recording of this call is now available on the company's website at www.advancedenzymes.com/investors/analystcorner.
The company has also indicated that the transcript of the conference call will be intimated to the stock exchanges in due course and will be uploaded on the same website link. All this information is being uploaded on the company's website as part of regulatory compliance.